AdventHealth
R

FLOW: The First Dedicated CKD Outcomes Trial With a GLP-1 Receptor Agonist

By AdventHealth FEATURING Richard Pratley
By AdventHealth FEATURING Richard Pratley
39 views
September 17, 2024
0 Comments
Login to view comments. Click here to Login

Featured Video

04:47
Novartis Cardiology

Examining MOA, Safety, and Efficacy Data for a Non-Statin Lipid-Lowe…

Featured Video

18:06
Lilly Obesity

Getting Patients Started with an Obesity Treatment Option for Adults

Feat. E. Lazarus

Related Content

AUTOPLAY
06:38
Allan Jaffe

What Does Elevated Troponin Mean in COVID-19?

64:45
Symposium on Diabetes and Cancer 2017: Novel Links and Treatments

Primer on Diabetes Management

Feat. S. Inzucchi
11:25
ACC 2023 Conference Coverage

ACC 2023: SGLT2i Use - Dos and Don'ts

Feat. A. Armbruster
18:43
ASPC 2019 Congress on CVD Prevention

Diabetes Treatment Guidelines Finally Have Entered the 21st Century …

Feat. R. DeFronzo
15:06
Robert Busch

GLP-1/GIP Update: Stay Tuned... The Best is Yet to Come!!

12:26
Juan Frias

SURPASS 2: Tirzepatide Versus Once-Weekly Semaglutide

27:24
Cardiometabolic Health Congress (CMHC)

SGLT2 Inhibitors, GLP1 Receptor Agonists, and Renal Outcomes

Feat. L. Sloan
15:33
Ken Fujioka

Could GLP-1's be a 'Game Changer' For Weight Loss? Ca…

26:49
Diana Isaacs

Tirzepatide Updates

20:24
Diana Isaacs

Tirzepatide for Type 2 Diabetes

08:35
Susan Brian

Labs to Check on Semaglutide or Tirzepatide

21:19
Patricia Kao

Cardio-Renal Syndrome Management: What Are the Key Factors That Impa…

07:41
Susan Brian

Weightloss in Menopause

19:23
PKD Foundation

Genetic Testing in PKD: The Benefits and the Challenges

Feat. L. Noureddine
06:31
Susan Brian

Discussing Retatrutide: A GIP, GLP-1, and Glucagon Receptor Agonist

05:08
Susan Brian

The Differences Between the Products of GLP1's and GLP/GIPs

32:27
Scripps Health

Obesity: A Serious Cardiovascular Risk Factor? A Review of GLP-1 Rec…

Feat. L. Vincent
36:34
Scripps Health

GLP-1 Hysteria

Feat. S. Harris
41:38
University of Colorado Department of Medicine

Artificial Intelligence & CHAT GPT in Nephrology

Feat. S. Ambruso
38:09
Houston Methodist

Multimodal Integrative Approach to Kidney Disease: Dietary Managemen…

Feat. K. Kalantar-Zadeh